Sanofi Beats Appeal To Nix Insulin Dose Patent
European officials rejected Roche Diabetes Care's challenge to Sanofi-Aventis' patent for a device that calculates insulin doses for people with diabetes, finding the opposition relied on an earlier design that lacked a...To view the full article, register now.
Already a subscriber? Click here to view full article